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anomalies than a left-sided or bilateral EIF in our study. We recom-
mended that fetuses should be offered a careful echocardiography as
soon as right-sided EIF was showed.
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OBJECTIVES To analyze the echocardiographic features of absent
pulmonary valve syndrome (APVS).
METHODS The echocardiographic ﬁndings were retrospectively
analyzed in seven fetuses with APVS and the echocardiographic fea-
tures of APVS were summarized.
RESULTS Of all seven fetuses with APVS, all of which demonstrated
cardiac enlargement, the axis of the heart was to the left and the main
pulmonary artery or branches were signiﬁcantly dilated. The pulmo-
nary valve was absent or rudimentary. Color Doppler ﬂow imaging
demonstrated severe pulmonary regurgitation. Spectral Doppler im-
aging showed stenosis of the pulmonary annulus. Four fetuses asso-
ciated with tetralogy of Fallot, one case of which associated with small
foci in the left ventricle and one case associated with single umbilical
artery. Two fetuses associated with right aortic arch. Two fetuses
associated with double outlet of right ventricle. One fetus associated
with atresia of mitral valve, right-ventricle typed single ventricle. One
fetus associated with double outlet of right ventricle. One fetus
associated with ventricular septal defect. Three fetuses associated
with absent ductus arteriosus.
CONCLUSIONS The fetal echocardiographic ﬁndings of the APVS are
characteristic and the APVS should be considered when markedly
dilated right ventricle and dilated pulmonary arteries in combine with
the stenosis and severe regurgitation of the pulmonary annulus.
Identifying whether or not the ductus arteriosus is present can help in
evaluating the prognosis.
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OBJECTIVES To summarize the fetal echocardiography characteristic
and prognosis in agenesis of the ductus venosus (ADV) with abnormal
umbilical vein connection patients.
METHODS Retrospective analysis of 14 fetuses with ADV by fetal
echocardiography. Analysis the size of heart, changes in heart func-
tion and prognosis.
RESULTS Fourteen cases ADV have been detected since January 2011
to November 2014. In six of them the umbilical vein was connected to
the portal vein (ﬁve to the left and one to the right), whereas of them
the umbilical vein neither drained to the left portal nor right portal
vein in the other eight cases. The umbilical vein connection to the
extrahepatic venous system by tracking detection ( ﬁve of them the
connection was directly to the right atrium, one directly to the inferior
vena cava, one to the right hepatic vein and the other drained into the
right atrium through coronary sinus).
CONCLUSIONS Prenatal ultrasound can be used to diagnose the ADV
accurately. Furthermore, it can be used to observe the umbilical vein
abnormal connection intrahepatic or extrahepatic and measure pipe
diameter. It will help to determine the prognosis and consultation.
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OBJECTIVES This study aims to validate transmural strain gradient of
myocardium measured by layer-speciﬁc strain imaging in different
subjects.METHODS Totally ninety-eight subjects were enrolled in this study,
including 38 healthy people, 33 patients with cardiovascular risk
factors but no coronary disease or heart failure (high-risk group) and
27 patients with heart failure. Usinglayer-speciﬁc strain imaging, peak
longitudinal strain (PLS) and peak circumferential strain (PCS) of all
three layers’ myocardium were measured in the three groups Thirty-
eight healthy subjects, thirty-three patients with cardiovascular
risk factors whose coronary angiogram is negative () and twenty-
seven patients with heart failure were enrolled in this study. By using
layer-speciﬁc strain imaging, Peak longitudinal strain (PLS) and
peakcircumferential strain (PCS) ofall three layers’ myocardium were
measured in three groups.
RESULTS The PLS and PCS of endo-, mid-, and epi-myocardium
(PLSendo, PLSmyo, PLSepi; PCSendo, PCSmyo, PCSepi) decreased
gradually in all three groups (P<0.001). The PLS and PCS of all the
three layers were signiﬁcantly lower in group with heart failure
than in other two groups (P<0.001). There were no signiﬁcantly
differences in PLSendo, PLSmid, and PCSendo between healthy sub-
jects and high-risk group.But the strain gradient among the three
layers (PLSendo-myo, PLSmyo-epi, PLSendo-epi; PCSendo-myo,
PCSmyo-epi PCSendo-epi) had statistically signiﬁcant differences in
three groups (healthy subjects > risk group > heart failure group)
(l p<0.001).
CONCLUSIONS There is a gradient of myocardial strain in PLS and
PCS, both of which decrease gradually in the order of endo-, mid- and
epi-myocardial strain in all groups., Compared with peak myocardial
strain, differences of gradient in layer strain are more sensitive to
detect early myocardial injury than peak myocardial strain.
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OBJECTIVES Pharmacological stress with adenosine triphosphate
(ATP) for myocardial perfusion imaging (MPI) has been used for many
years. However, the incidence of their side effects reported are
different. The purpose of this study is to investigate prospectively the
incidence of chest pain, dyspnea and headache, the most common
three symptoms during ATP infusion.
METHODS Five-minutes ATP stress was performed. In brief, ATP was
infused (0.16mg/kg.min) with pump for ﬁve minutes and stopped at
5 minutes; Tc-99m MIBI was injected at 3 minute during ATP infusion.
The heart rate (HR) and blood pressure (BP) were taken down before
ATP infusion, at 3 and 5 minutes during ATP infusion. The patient’s
3-minutes HR increased 5 times per minute or more than that of
pre-ATP infusion was determined “increasing HR”. The patient’s
3-minutes systolic blood pressure (SBP) decreased 5 mmHg or more
than that of pre-ATP was determined as “decreasing SBP”. Gated MPI
was performed 120 minutes later.
One hundred and thirty-seven patients included in this prospective
study from Feb 2014 to May 2014. Patients underwent ATP stress for
suspected CAD or for differentiating CAD from other disease. Among
them, 53 patients had suspected CAD, 27 patients had suspected
dilated cardiomyopathy (DCM), 28 patients had joint disease of lower
limbs for preoperative risk stratiﬁcation, other patients had suspected
myocarditis, chronic obstructive pulmonary disease (COPD), and
rheumatic heart disease.
RESULTS One hundred thirty-six of the 137 included patients taken
down all of the side effects. Among the 136 patients, 82 patients
(60.29%) had chest pain, 76 (55.88%) had dyspnea and 52 (38.24%)
had headache during ATP infusion. The 136 patients were classiﬁed
four groups according to numbers of symptoms; asymptomatic pa-
tients was 14.71% (20/136), patients with one symptom was 29.41%
(40/136), patients with two symptoms was 42.65% (58 /136) and pa-
tients with three symptoms was 13.24% (18/136).
One hundred and thirty-ﬁve patients of the 137 included patients
taken down the blood pressure during ATP infusion. Ninty-ﬁve of the
135 patients (70.37%) decreased SBP (38.1612.41mmHg) during ATP
infusion. Twenty of the them (22.22%) increased their SBP
(10.753.49mmHg), and 20 patients (22.22%) changed little SBP.
We taken notes of all the heart rates of the 137 patients during the
ATP infusion. Ninety-eight patient’s (71.53%) HR increased
(17.99.92), and 14 patient’s (10.22%) HR decreased (11.575.09)
during ATP infusion. Twenty-ﬁve (18.25%) patient’s 3-minutes HR had
little change during ATP infusion.
